Aspirin therapy and risk of subdural hematoma: Meta-analysis of randomized clinical trials

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 4, 2013, Pages 444-448

  Connolly, Ben J ^a   Pearce, Lesly A ^b   Kurth, Tobias ^c   Kase, Carlos S ^d   Hart, Robert G ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Biostatistical Consulting   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiplatelet therapy; antithrombotic therapy; aspirin; complications; intracranial hemorrhage; subdural hematoma

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; ARTICLE; DISEASE PREDISPOSITION; HEALTH PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBDURAL HEMATOMA; SYSTEMATIC REVIEW; AGE; AGED; CHEMICALLY INDUCED; CONTROLLED STUDY; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT; RISK FACTOR;

AGE FACTORS; AGED; ASPIRIN; HEMATOMA, SUBDURAL; HUMANS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84877037664     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.01.007     Document Type: Article

References (27)

1. M.C. Fang, A.S. Go, and Y. Chang Death and disability from warfarin-associated intracranial and extracranial hemorrhages Am J Med 120 2007 700 705
2. J. Huhtakangas, S. Tetri, and S. Juvela Effect of increased warfarin use on warfarin-related cerebral hemorrhage. A longitudinal population-based study Stroke 42 2011 2431 2435
3. S.J. Connolly, J. Eikelboom, and J. Ng Weighted net clinical benefit of addition of clopidogrel to aspirin in patients with atrial fibrillation unsuitable for a vitamin K antagonist Ann Intern Med 155 2011 579 586
4. D.F. O'Brien, S. Basu, and J.R. O'Donnell The impact of aspirin therapy and anticoagulation on the prevalence of subdural hematoma Ir Med J 93 2000 244 246
5. P. Lindvall, and L.O. Koskinen Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural hematomas J Clin Neurosci 16 2009 1287 1290
6. T. Rust, N. Kiemer, and A. Erasmus Chronic sudural haematomas and anticoagulation or antithrombotic therapy J Clin Neurosci 13 2006 823 827
7. Antithrombotic Trialists' Collaboration Collaborative metanalysis of randomised of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients BMJ 324 2002 71 86
8. Antithrombotic Trialists' (ATT) Collaboration C. Baigent, and L. Blackwell Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomized trials Lancet 373 2009 1849 1860
9. J.S. Berger, M.J. Krantz, and J.M. Kittelson Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease. A meta-analysis of randomized trials JAMA 301 2009 1909 1919
10. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
11. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17 1996 1 12
12. M.J. Sweeting, A.J. Sutton, and P.C. Lambert What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data Stat Med 23 2004 1351 1375 Erratum: Stat Med 2006;25:2700
13. Stroke Prevention in Atrial Fibrillation Investigators The Stroke Prevention in Atrial Fibrillation Study: Final results Circulation 84 1991 527 539
14. S. Juul-Moller, N. Edvardsson, and B. Jahnmatz Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris Lancet 340 1992 1421 1425
15. H. Sato, K. Ishikawa, and A. Kitabatake Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial Stroke 37 2006 447 471
16. H. Ogawa, M. Nakayama, and T. Morimoto Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes JAMA 300 2008 2134 2141
17. Steering Committee of the Physicians' Health Study Research Group Final report of the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
18. H.C. Diener, L. Cunha, and C. Forbes European Stroke Prevention Study 2. Dipyridamole and acetylsalicyclic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13
19. L. Hansson, A. Zanchetti, and S.G. Carruthers Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomized trial Lancet 351 1998 1755 1762
20. P.M. Ridker, N.R. Cook, and I.M. Lee A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 2005 1293 1304
21. F.G. Fowkes, J.F. Price, and M.C. Stewart Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: A randomized controlled trial JAMA 303 2010 841 848
22. R.G. Hart, J.L. Halperin, and R. McBride Aspirin for the primary prevention of stroke and other major vascular events Arch Neurol 37 2000 326 332
23. E.M. Hylek, and D.E. Singer Risk factors for intracranial hemorrhage in outpatients taking warfarin Ann Intern Med 120 1994 897 902
24. R.G. Hart, H.C. Diener, and S. Yang Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: The RE-LY trial Stroke 43 2012 1511 1517
25. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation. The ATRIA study Ann Intern Med 151 2009 297 305
26. S.J. Connolly, J. Pogue, and R.G. Hart Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
27. J. Mant, F.D. Hobbs, and K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial Lancet 370 2007 493 503